One is usually seen as more targeted, the other as more systemic, so using both is meant to cover more recovery pathways
Couture Med Spa reports a similar pattern among its own tirzepatide and semaglutide patients, listing mild nausea or upset stomach, temporary irritation at the injection site, fatigue or headaches, and changes in appetite, and adds that most side effects fade as the body adjusts to treatment (couturemedspa.com)
Changes to the Grocery and Restaurant Industries Changes to appetite and diet related to GLP-1 use are being reflected in retail
Tirzepatide (Mounjaro, Zepbound) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management
However, as aforementioned, due to the lack of a placebo group, high baseline C-peptide levels, and concomitant use of a restricted carbohydrate diet, these results are difficult to interpret or extrapolate to other populations
issue-2/hmbci-2017-0002/hmbci-2017-0002.xml (2017)